secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2022-12-06T23:59:59+00:00
Accession:  0001077183-22-000197
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics appoints Jeffrey S. Sherman as CFO; William Bonello steps down
--------------------------------------------------------------------------

- Jeffrey S. Sherman named CFO effective Dec 7, 2022; William Bonello remains as employee for transition support.
- Base salary $525,000; annual target bonus 70% of salary; sign-on cash $250,000; sign-on equity $3,000,000 (RSUs and options).
- Sherman has 32 years healthcare finance experience, previously CFO at Privia Health, HMS, AccentCare, Lifepoint Hospitals.
- Sherman led the sale of HMS to Veritas-backed Gainwell Technologies for $3.4 billion in April 2021.
- CEO Chris Smith highlights Sherman's skills in pricing, revenue cycle management to return NeoGenomics to profitable growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/0001077183-22-000197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000197/neo-20221205.htm
  HTML page:      https://secwatch.observer/filing/0001077183-22-000197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer